Submission of Investor Presentation on Unaudited Financial Results for Q1 of FY 2024-25.
10-Aug-2024
Download PDF
Aurobindo Pharma
Submission of Investor Presentation on Unaudited Financial Results for Q1 of FY 2024-25.